U.S. Food and Drug Administration Approves Longeveron's Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart ConditionGlobeNewsWire • 11/18/21
Longeveron Inc. (LGVN) CEO Geoff Green on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/12/21
Longeveron Inc. Provides Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/12/21
DEADLINE FRIDAY REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/10/21
Last Days to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLCNewsfile Corp • 11/10/21
FRIDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/09/21
FRIDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/08/21
Longeveron to Release Third Quarter 2021 Financial Results and Hold Conference Call on November 12, 2021GlobeNewsWire • 11/08/21
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Longeveron Inc. of Class Action Lawsuit and Upcoming Deadline - LGVNNewsfile Corp • 11/08/21
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – LGVNBusiness Wire • 11/07/21
7-DAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Longeveron Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 11/05/21
Last Few Days to Actively Participate in Longeveron Inc. (LGVN) Class Action - Bronstein, Gewirtz & Grossman, LLCBusiness Wire • 11/05/21
Longeveron Selects Clinical Research Organization for Phase 2 Alzheimer's Disease TrialGlobeNewsWire • 11/05/21
APPROACHING DEADLINE REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Longeveron Inc. And Encourages Investors With Losses In Excess Of $100,000 To Contact The FirmNewsfile Corp • 11/03/21
SHAREHOLDER ALERT: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Longeveron Inc. (LGVN)Business Wire • 11/03/21
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action - LGVNNewsfile Corp • 10/31/21
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Longeveron Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action - LGVNPRNewsWire • 10/28/21
SHAREHOLDER ALERT- LONGEVERON INC. (LGVN) LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Longeveron Inc.Newsfile Corp • 10/26/21
INVESTOR ALERT- LONGEVERON INC. (NASDAQ: LGVN) SHAREHOLDER CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against the Longeveron Inc.PRNewsWire • 10/21/21
